Equity Investing
Brooklyn ImmunoTherapeutics, Inc. (BTX) Stock Skyrocketing Since Acquisition of Exclusive License
Brooklyn ImmunoTherapeutics, Inc. (BTX) stock prices were up a monumental 57.63% as of market close on May 3rd, 2021, bringing the price per share up